Jin Medical International (ZJYL) Cash & Equivalents (2023 - 2025)

Jin Medical International has disclosed Cash & Equivalents across 3 years of filings, most recently posting $7.5 million for Q3 2025.

• Cash & Equivalents for Q3 2025 came in at $7.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $7.5 million (changed N/A YoY), and the FY2025 annual result was $7.5 million, changed N/A from the prior year.
• Cash & Equivalents came in at $7.5 million for Q3 2025 at Jin Medical International, down from $8.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $8.1 million in Q1 2025 to a low of $4.8 million in Q1 2023.
• The 3-year median for Cash & Equivalents is $7.2 million (2024), against an average of $6.8 million.
• Across the five-year window, Cash & Equivalents soared 44.59% in 2024 and rose 17.41% in 2025, its largest moves.
• Jin Medical International's Cash & Equivalents stood at $4.8 million in 2023, then jumped by 44.59% to $6.9 million in 2024, then grew by 7.68% to $7.5 million in 2025.
• The last three Cash & Equivalents figures came in at $7.5 million (Q3 2025), $8.1 million (Q1 2025), and $6.9 million (Q1 2024), per Business Quant data.